You are here: Home / Archives for Pharmaceuticals

Drug ending soon issue emergency response system – pharmaceutical – pharmaceutical industry trade

July 15, 2011 By Leave a Comment

Article by jekky

(621, ‘National Drug emergency response system issue after six months of the project deployment research analysis and research work now nearing completion quot China should gradually explore the establishment of a government led military cooperation stress on the latter the whole society to participate in a new system of medicine emergency protection order to protect the public in major emergencies and effective drug supply quot At the recent quot national emergency response system of medicines quot the seminar topics the NPC Standing Committee Vice Chairman China Pharmaceutical Association of the case said Sang Guowei Conference the National Development and Reform Commission the State Ministry of Industry and Information Technology Ministry of Health the State Food Drug Administration the State Medicine Authority the General Logistics Department and the Ministry of Health World Health Organization and other relevant departments leading experts on the formation of the final report put forward constructive comments and suggestions System initially built needs improvement quot Emergency response system of national drug quot was included in the national quot 12 5 quot major issues of pre planning issues by the National Development and Reform Commission approved the project the deployment of mission earlier this year In February this year the bear will be the subject of Chinese medicine experts on natural disasters and Guangdong Sichuan Fujian and Beijing Shanghai Zhejiang Hubei Hunan Heilongjiang and other emergency drugs focus on reserves provinces and cities to focus on the investigation and 30 large general hospitals and specialist hospitals and doctors took part in emergency relief medicine nursing and management staff conducted a survey and interviews Present China has preliminarily established the central and local levels medical reserve system and formed a quot unified leadership overall coordination hierarchical accountability local management based quot emergency management system However the research group in the survey found that emergency response system on drug policy protection reserves and other still needs improvement such as pharmaceutical pricing policies lead to shrinking reserves of the value of drugs some special varieties in the disaster highlighted the contradiction between supply and demand after leading to the procurement costs Medicine reserves the infrastructure is relatively weak lack of uniform drug storage database quot And the medical reserves normative documents related to the sector has not increased regulations and state laws and regulations levels is not conducive to the rescue according to the law in drugs policy in the reserves the reserves over the form of a single reserve catalog no dynamic amendments lack of uniform standards throughout the catalog central and local lack of coordination between the Reserve List pharmaceutical standards and processing donations disaster medical personnel to practice emergency Drug Quality Management of green channel a special emergency use of drugs and medicines are also missing after the disaster with the disposal of the appropriate legal basis quot China Pharmaceutical University International Business School Dean of Medicine said Shao Rong China Pharmaceutical Group Corporation Director of Planning and Development Shi Sheng Yi pointed out that emergency medicine category and product regulations can not fully meet Epidemic Complex and changeable difficult to control the number of physical reserves such as SARS vaccine and other special varieties if usually a large number of reserves will result in waste quot At present the real reserves and capital reserve ratio between 7 3 this ratio is to make some changes quot Peking University Guanghua School of Management of Health Economics and Management Gordon Liu questioned Gordon Liu drugs during the emergency funds subject protection study concluded that the current contingency reserves on drug adjustment still can not meet the task to increase reserve requirements reserves of drugs yet to be complete write off compensation mechanism Emergency procurement of special funds is still blank ‘)

The e-commerce company in China offers quality products such as China 12PSB Test Bench, China CP-60 Current Probe , and more. For more, please visit rail repair tools today!

Find More Pharmaceuticals Articles

Filed Under: Pharmaceuticals Tagged With: , , , , , , , ,

Lead the children in Hainan Kang Chi Pharmaceutical analgesic market – Pharmaceutical – Pharmaceutic

July 15, 2011 By Leave a Comment

Article by hi joiney

Be listed on the GEM of Hainan Kang Chi Pharmaceutical Co., Ltd. (300086), is mainly engaged in child drug research and development, production and sales. Production and operation of five kinds of dosage forms currently 11 children in drug types, covering children in our country’s largest-selling drug paracetamol, cold, antibiotics, respiratory, digestion and nutrition, the frightened and the six major categories of Western medicine and Chinese patent medicines, is China’s largest specialized manufacturer of children’s medicine.

Hong Chi Pharmaceutical main products include Ruizhi Qing (Nimesulide granules), cefminox sodium injection, cough orange-red particles (two Chinese state protected species), cold heat particles and other varieties. Among them, the treatment of children with antipyretic analgesics in the Western Ruizhi Qing is the company’s leading product, similar products in the country and children antipyretic analgesic products in the sales of the first, in 2009 the market share reached 18.20%, constitute the company main business revenue and profit source. Rui Zhiqing 2007, 2008 and 2009 annual sales were 1.82 billion yuan, 316 million yuan and 5.56 billion yuan, an annual growth rate was 73.63% and 75.95%.

Hong Chi Pharmaceutical is the first market focus on the enterprise market in the third end, and the third terminal market, according to the characteristics of the interests of all sectors of the industry chain and functions were integrated, rolled out a package innovative marketing model??? professional co-agent model, the establishment of a flat distribution network structure, can readily respond to market demand, low-cost way to quickly sell drugs to end customers. So far, the company has established a professional marketing team the third terminal and marketing children’s drugs network in the country has nearly a thousand agents and more than 30,000 sales terminals, terminal market in the third start with the obvious advantage.

With the company’s marketing network constantly expanding and deepening the market share of other products also increased year by year. Meanwhile, the Hong Chi medicine operated in early 2009 bought ammonia Jinhuang Min particle, cefaclor particles carbocisteine particles Jian’erle calcium particles and particles of Portuguese children four-dimensional products is rapidly opening up the sale situation, the formation of new profit growth.

Healthy market and product development, a strong impetus to R & D strength, talent pool, quality management in leaps and bounds. At present, the company has 25 drugs in various stages of development, there are three types of drugs reported five new drugs, five drugs 6, all drug products for children. Abundant reserves of new drug development has become a long-term sustained growth of the company’s future core strengths.

After nearly ten years of operation, Hong Chi Pharmaceutical drugs in the field of children, particularly children, drug market in the third terminal has established a good brand, “Kang Chi” brand has been recognized by many consumers, leading products, “Swiss Chi Ching “in the children’s antipyretic and analgesic drug market enjoys a high reputation. Hong Chi Pharmaceutical

planning to issue 2,500 shares of this, the total issued share capital of 10,000 million shares after. Raise funds to invest in four projects: children’s drug production base construction project, the marketing network construction projects, medical research and development center and other projects associated with the main business working capital items. In the long term, the project will help raise funds to achieve economies of scale the company to reduce unit production costs, enhance competitive advantage and further enhance the company’s main revenue and profit levels.

disposablemedicalsuppliers.com offers high quality suppliers and high quality products, such as Disposable Anal Speculum, Disposable Vaginal Speculum <a href=”http://www.disposablemedicalsuppliers

More Pharmaceuticals Articles

Filed Under: Pharmaceuticals Tagged With: , , , , , ,

Retail Business will have a medical drama – retail, pharmaceutical – pharmaceutical industry

July 15, 2011 By Leave a Comment

Article by hi joiney

Currently, the industry retail formats on the medicine continue to explore the direction of development and forecasting, but most are based on a period of a few companies in the development of inference. The author believes that the development of Chinese Retailing forecasts in addition to less than full induction to study, but also can be applied system dynamics approach, deep into the Chinese retail formats affect intrinsic motivation and extrinsic motivation to conduct inference in. Theory does not explain the current Retailing developments and changes in the domestic retail formats Pharmaceutical retail industry when it began, “Ye Tai” concept has been difficult to research, the author information by the parties to judge, pharmaceutical retail industry, “Ye Tai,” the seed of the concept should begin in the last century in the late 90′s, pharmaceutical retail industry began to find China’s retail industry, the various Yetai ongoing changes in the industry have to go abroad to see the foreign pharmaceutical retailer and gradually expand the variety of ideas. In 2001, the “Ye Tai” is more of concern to pharmacy operators. Due to policy constraints, imperfect competition, the special characteristics of drugs, pharmaceutical development of Retailing in China relative to the entire retail industry, to become slow and tender, but in recent years and very quickly at home and abroad in the reference and absorption the development of various retail formats manner, showing a diversity of characteristics. In the retail industry, the research on the theory of development may include: retail transmigration theory, dialectical development of theory, accordion theory, natural selection theory, life-cycle theory, each theory can explain the evolution of retail formats as part of the phenomenon. For example retail transmigration theory can explain China’s department stores, supermarkets, hypermarkets led in turn causes; dialectical development of theory to explain the interaction between different retail formats imitate, learn from the causes; accordion theory may explain why the department store, specialty store, shopping Centre alternating; natural selection theory can explain why Japan’s retail overlord is Mitsukoshi department store, supermarket Daiei and Ito-Yokado GMS ,7-11 convenience stores. These theories to our understanding of some of the changes the retailer and medicine have been positive, but can not fully explain and predict the development of Chinese medicine Retailing. The reason, I believe that is due to the soil produced by the West Yetai theory of homogenization based on the environment and fully competitive market, while China is different. Specific for the following reasons: Policy uncertainty Drugs both commodities, but also save lives of non-commodity attributes (life and health is priceless), the state strictly controls the pharmaceutical industry. Therefore, the Chinese pharmaceutical retailing industry is affected by the policy very large non-fully competitive market, format development will be greatly influenced by policy. The national policy since the game between different interest groups, with considerable uncertainty. The unbalanced nature of the environment Uneven social and economic development of China itself, from east to west, a considerable difference in economic development environment, which also makes different Yetai development in different environments on their own, fend for themselves. Change of True in the pharmaceutical retail industry, the rapid development of the 21st century, technological change (such as information technology) is very fast, a big influence. Similarly, the concept of innovation and management innovation is also the ups and downs, these are the development of the pharmaceutical retail formats work. From the system point of view of the top five pharmaceutical Retailing external reason From the system point of view on the development of pharmaceutical retail formats can be found at different stages, some external reason, or intrinsic motivation in different environments will play a leading role, making Chinese retail formats to adapt to the dominant factor towards direction, so that the entire Yetai balanced. Once the other major changes in motivation destroyed this balance, Ye Tai begin a new round of evolution. The Development of Retailing in China’s pharmaceutical short time, many enterprises, business environment differs greatly from a dominant factor in the evolution of the process leading Yetai, there have been other significant changes in motivation, which makes the development may change the direction of shock. Development of Retailing dominant intrinsic motivation are different in every business, but there is some external motivation in common. For example, the impact of pharmaceutical external reason the retailer has five aspects:

We are high quality suppliers, our products such as Lug Butterfly Valve , Lug Butterfly Valve for oversee buyer. To know more, please visits Lug Butterfly Valve.

More Pharmaceuticals Articles

Filed Under: Pharmaceuticals Tagged With: , , , ,